HeartbeamBEAT
Market Cap: 69.8M
About: HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
Employees: 13
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
0.05% less ownership
Funds ownership: 7.77% [Q4 2023] → 7.71% (-0.05%) [Q1 2024]
8% less capital invested
Capital invested by funds: $4.8M [Q4 2023] → $4.43M (-$372K) [Q1 2024]
19% less funds holding
Funds holding: 31 [Q4 2023] → 25 (-6) [Q1 2024]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Research analyst outlook
2 Wall Street Analysts provided 1 year price forecasts over the past 6 months
2 analyst ratings
Benchmark Bill Sutherland | 202%upside $8 | Speculative Buy Reiterated | 13 May 2024 |
Benchmark Bill Sutherland | 202%upside $8 | Speculative Buy Reiterated | 25 Mar 2024 |